ESMO scientific and educational resources on this topic!
Recent medwireNews and resources from conferences are for ESMO Members only.
Rare Cancers
Sarcoma & GIST plus CUP
Latest ESMO videos
Meeting resources
1521O - A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultra-rare cancer with highly life-threatening unmet medical needs (NCCH1806/MK004)
Presenter: Yuki Kojima
Session: Proffered Paper session - Sarcoma
Resources:
Abstract
654MO - A phase II prospective trial of frontline cabozantinib in metastatic collecting ducts renal cell carcinoma: The BONSAI trial (Meeturo 2)
Presenter: Giuseppe Procopio
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Abstract
1524MO - Patterns of care and outcomes of 64 CIC-rearranged sarcoma: A retrospective multicentre case-series within the French Sarcoma Group (FSG)
Presenter: Brahmi Mehdi
Session: Mini oral session - Sarcoma
Resources:
Abstract
1522MO - Hormonal contraception and pregnancy and risk of progression or relapse in desmoid-type fibromatosis (DF)
Presenter: Marion DEBAUDRINGHIEN
Session: Mini oral session - Sarcoma
Resources:
Abstract
963MO - Naxitamab for the treatment of refractory/relapsed high-risk neuroblastoma (HR NB): Updated efficacy and safety data from the international, multicenter phase II trial 201
Presenter: Jaume Mora
Session: Mini oral session - Investigational immunotherapy
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.